Announcements Trials

Browse Landscape

Phase

Status

Completed 16 Withdrawn 2 Terminated 2 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8 Other hematologic neoplasm 4 Head & Neck 4 Sarcoma 2 Tumor-Agnostic 1 Myeloid 1 Lymphoid 1 Endocrine 1 Dermatologic 1 CNS 1

Conditions

Recurrence 1 Neuroblastoma 1

Interventions

Temozolomide 59 Radiotherapy 37 Magnetic Resonance Spectroscopy 32 Radiosurgery 27 Specimen Handling 23 Cyclophosphamide 21 pembrolizumab 20 Nivolumab 20 Radiation 17 Carboplatin 12 Biopsy 12 Bevacizumab 11 Vincristine 10 Ipilimumab 10 Cisplatin 10 X-Rays 9 Lomustine 8 Irinotecan 8 Immunoglobulin G 8 Etoposide 8 trametinib 7 Disulfides 7 AZD 6244 7 pertuzumab 6 atezolizumab 6 abemaciclib 6 Topotecan 6 Proton Therapy 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sorafenib × CNS × Clear all

NCT02298348 2026-03-23

N2013-02

New Approaches to Neuroblastoma Therapy Consortium

Phase 1 Active not recruiting

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡